Cancer Biology Graduate Program, Vanderbilt University, Nashville, Tennessee.
Division of Allergy, Pulmonary, and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
Cancer Res Commun. 2023 Jul 26;3(7):1350-1365. doi: 10.1158/2767-9764.CRC-22-0373. eCollection 2023 Jul.
Lung adenocarcinoma (LUAD) is a heterogeneous group of tumors associated with different survival rates, even when detected at an early stage. Here, we aim to investigate the biological determinants of early LUAD indolence or aggressiveness using radiomics as a surrogate of behavior. We present a set of 92 patients with LUAD with data collected across different methodologies. Patients were risk-stratified using the CT-based Score Indicative of Lung cancer Aggression (SILA) tool (0 = least aggressive, 1 = most aggressive). We grouped the patients as indolent ( 0.4, = 14), intermediate (0.4 0.6, = 27), and aggressive (0.6 1, = 52). Using Cytometry by time of flight (CyTOF), we identified subpopulations with high HLA-DR expression that were associated with indolent behavior. In the RNA sequencing (RNA-seq) dataset, pathways related to immune response were associated with indolent behavior, while pathways associated with cell cycle and proliferation were associated with aggressive behavior. We extracted quantitative radiomics features from the CT scans of the patients. Integrating these datasets, we identified four feature signatures and four patient clusters that were associated with survival. Using single-cell RNA-seq, we found that indolent tumors had significantly more T cells and less B cells than aggressive tumors, and that the latter had a higher abundance of regulatory T cells and Th cells. In conclusion, we were able to uncover a correspondence between radiomics and tumor biology, which could improve the discrimination between indolent and aggressive LUAD tumors, enhance our knowledge in the biology of these tumors, and offer novel and personalized avenues for intervention.
This study provides a comprehensive profiling of LUAD indolence and aggressiveness at the biological bulk and single-cell levels, as well as at the clinical and radiomics levels. This hypothesis generating study uncovers several potential future research avenues. It also highlights the importance and power of data integration to improve our systemic understanding of LUAD and to help reduce the gap between basic science research and clinical practice.
肺腺癌(LUAD)是一组异质性肿瘤,即使在早期发现,其生存率也不同。在这里,我们旨在通过放射组学作为行为的替代物来研究早期 LUAD 惰性或侵袭性的生物学决定因素。我们展示了一组 92 名 LUAD 患者的数据,这些数据是通过不同的方法收集的。患者使用基于 CT 的肺癌侵袭性评分工具(SILA)进行风险分层(0 = 侵袭性最低,1 = 侵袭性最高)。我们将患者分为惰性组(0.4, = 14)、中间组(0.4 0.6, = 27)和侵袭性组(0.6 1, = 52)。使用飞行时间质谱流式细胞术(CyTOF),我们鉴定了具有高 HLA-DR 表达的亚群,这些亚群与惰性行为相关。在 RNA 测序(RNA-seq)数据集,与免疫反应相关的通路与惰性行为相关,而与细胞周期和增殖相关的通路与侵袭性行为相关。我们从患者的 CT 扫描中提取了定量放射组学特征。整合这些数据集,我们鉴定了四个特征签名和四个与生存相关的患者聚类。使用单细胞 RNA-seq,我们发现惰性肿瘤比侵袭性肿瘤具有更多的 T 细胞和更少的 B 细胞,而后者具有更高比例的调节性 T 细胞和 Th 细胞。总之,我们能够揭示放射组学和肿瘤生物学之间的对应关系,这可以提高对惰性和侵袭性 LUAD 肿瘤的区分能力,增强我们对这些肿瘤生物学的认识,并为干预提供新的和个性化的途径。
本研究在生物学整体和单细胞水平以及临床和放射组学水平全面分析了 LUAD 的惰性和侵袭性。这项假设产生的研究揭示了几个潜在的未来研究方向。它还强调了数据集成的重要性和力量,以提高我们对 LUAD 的系统理解,并帮助缩小基础科学研究与临床实践之间的差距。